Echo Street Capital Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,786
Closed -$329K 600
2022
Q3
$329K Buy
2,786
+967
+53% +$147K ﹤0.01% 376
2022
Q2
$260K Buy
+1,819
New +$260K ﹤0.01% 451
2022
Q1
Sell
-4,048
Closed -$1.03M 696
2021
Q4
$1.03M Buy
4,048
+3,493
+629% +$1.02M 0.01% 241
2021
Q3
$214K Sell
555
-483
-47% -$178K ﹤0.01% 566
2021
Q2
$244K Sell
1,038
-840
-45% -$150K ﹤0.01% 519
2021
Q1
$246K Buy
+1,878
New +$272K ﹤0.01% 459

Other funds holding MRNA

Echo Street Capital Management's MRNA Position: Q4 2022 in Review

Echo Street Capital Management sold out of Moderna (MRNA) in Q4 2022, closing a stake of 2,786 shares — an estimated $329K sold.

Echo Street Capital Management first reported a position in MRNA in Q1 2021 and held it in 6 quarters. The position peaked at $1.03M in Q4 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Echo Street Capital Management reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Echo Street Capital Management sold 2,786 Moderna shares in Q4 2022, an estimated $329K.
  • Echo Street Capital Management first reported a position in Moderna in Q1 2021 and held it in 6 quarters.
  • Echo Street Capital Management's Moderna position peaked at $1.03M in Q4 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Echo Street Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.